• Responsible for the Marketing approach for a Oncology Product Portfolio: CABOMETYX® – SOMATULINE AUTOGEL® & ARVEKAP®.• Build high quality KOL management together with the Commercial Head, across specialties such as Oncology, Hepatology, Endocrinology, Urology.• Support marketing activities for Therapeutical Areas for each indication – brand.• Drive sales & marketing interface for excellence in implementation.• Develop analytical tools to track sales, uncover opportunities… Show more • Responsible for the Marketing approach for a Oncology Product Portfolio: CABOMETYX® – SOMATULINE AUTOGEL® & ARVEKAP®.• Build high quality KOL management together with the Commercial Head, across specialties such as Oncology, Hepatology, Endocrinology, Urology.• Support marketing activities for Therapeutical Areas for each indication – brand.• Drive sales & marketing interface for excellence in implementation.• Develop analytical tools to track sales, uncover opportunities, plan and measure activities. Show less

• Implement Ipsen’s Key Account business planning for Oncology Portfolio• Develop strong relationships with Customers and KOL in every Account

• Responsible for launching Cooper’s Ophthalmology Portfolio • Empower business relationships with local KOLs in Ophthalmology Area

• Plans and implements the commercial strategy for Ozurdex in line with the marketing • Develops professional relationships and builds KOLs advocacy• Facilitates listing of the company’s products in therapeutic guidelines by providing up-to-date medical support to KOLs

Responsible for the Anti Fungal portfolio managementExecution of the Country Anti Fungal Portfolio PlanLeading the execution of the 1st Cost - Effective study in the Anti Fungal market, with the National School of Public Heath support, regarding Noxafil use in Greek populationSelected member of Global team, for the IPad content relative to MSD Anti Fungal portfolio Optimization Market Research design to fine tune with strategy needsCoordinate with Market Access Dept. to… Show more Responsible for the Anti Fungal portfolio managementExecution of the Country Anti Fungal Portfolio PlanLeading the execution of the 1st Cost - Effective study in the Anti Fungal market, with the National School of Public Heath support, regarding Noxafil use in Greek populationSelected member of Global team, for the IPad content relative to MSD Anti Fungal portfolio Optimization Market Research design to fine tune with strategy needsCoordinate with Market Access Dept. to overcome access challengesNew campaigns & materials capturing the market needsOrganization & execution of key Events (advisory boards, satellite symposiums, hospital presentations)Budget allocation, follow up & forecastingScientific support and strategic guidance to the Anti Fungal sales force team Show less

Responsible for NOXAFIL and NETROMYCIN managementExecution of the Country Product planNew campaigns & materials capturing the market needsOrganization & execution of key Events (advisory boards, satellite symposiums, hospital presentations)Budget allocation, follow up & forecastingScientific support and strategic guidance to the Anti Fungal and AntiBiotic sales force team

Launching NOXAFIL and being responsible for the one third of the accounts in GreecePresentations to Key accounts increasing awareness for Noxafil1st in sales Product Specialist in 2007 for NoxafilExecuting projects to support the Noxafil Marketing Team

Responsible for the promotion of GLIVEC, SANDOSTATIN & DESFERALFocus mainly in hematology, oncology and endocrinology

Responsible for all the types of insulin and a compound for type 2 diabetes (novonorm)